The US Food and Drug Administration (FDA) has approved Gleevec (imatinib) to treat children who are newly diagnosed with a form of acute lymphoblastic leukemia (ALL).

For some children with acute lymphocytic leukemia (ALL) who don’t improve after initial induction therapy, more chemotherapy may work better than a stem cell transplant, according to a study.

Computed tomography (CT) scans in children have been linked to a small increased risk for later developing leukemia and brain cancer, according to a newly published study by international researchers.

A new study shows that children with the most common type of childhood cancer, acute lymphoblastic leukemia (ALL) have a survival rate of more than 90%.

A maker of the cancer drug methotrexate, Bedford Laboratories, has advised the FDA that it will release emergency supplies of preservative-free methotrexate to meet patients’ needs.

Survival has improved dramatically for kids with cancer over the past 30 years.